ARGENX SE-ADR Revenue 2017-2021 | ARGX

ARGENX SE-ADR annual/quarterly revenue history and growth rate from 2017 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • ARGENX SE-ADR revenue for the quarter ending June 30, 2021 was $M, a NAN% increase year-over-year.
  • ARGENX SE-ADR revenue for the twelve months ending June 30, 2021 was $0.193B, a INF% increase year-over-year.
  • ARGENX SE-ADR annual revenue for 2020 was $0.062B, a 32.65% decline from 2019.
  • ARGENX SE-ADR annual revenue for 2019 was $0.092B, a 167.93% increase from 2018.
  • ARGENX SE-ADR annual revenue for 2018 was $0.035B, a 25.97% decline from 2017.
ARGENX SE-ADR Annual Revenue
(Millions of US $)
2020 $62
2019 $92
2018 $35
2017 $47
2016 $19
ARGENX SE-ADR Quarterly Revenue
(Millions of US $)
2021-03-31 $167
2020-03-31 $26
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $15.975B $0.042B
argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71